Matrix metalloproteinase-9 (MMP-9) is expressed at lower levels than Matrix metalloproteinase-2 (MMP-2) in acute ischemic stroke (AIS) clots, but expression is increased by thrombolytic treatment

Karen Doyle

Matrix metalloproteinase-9 (MMP-9) is expressed at lower levels than Matrix metalloproteinase-2 (MMP-2) in acute ischemic stroke (AIS) clots, but expression is increased by thrombolytic treatment

Physiology

Research output: Chapter in Book or Conference Publication/Proceeding › Conference Publication › peer-review

Original language	English (Ireland)
Title of host publication	ESOC 2023
Publication status	Published - 1 Jan 2023

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Andrew Douglas, Abhay Pandit, Ray McCarthy, Michael Gilvarry, Eric Ceder, Dennis Dunker, Annika Nordanstig, Petra Redfors, Katarina Jood, Alan OHare, Sarah Power, Paul Brennan, András Nagy, Ágnes Vadász, Georgios Tsivgoulis, Klearchos Psychogios, Istvan Szikora, Turgut Tatlisumak, Alexandros Rentzos, John Thornton, Karen Doyle

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@inproceedings{a5e31fd8d8da4526b24b7dbefe8f9a1c,

title = "Matrix metalloproteinase-9 (MMP-9) is expressed at lower levels than Matrix metalloproteinase-2 (MMP-2) in acute ischemic stroke (AIS) clots, but expression is increased by thrombolytic treatment",

author = "Karen Doyle",

year = "2023",

month = jan,

day = "1",

language = "English (Ireland)",

booktitle = "ESOC 2023",

}